MicroRNA-specific argonaute 2 protein inhibitors

ACS Chemical Biology

Volumn 8, Issue 10, 2013, Pages 2122-2126

  Schmidt, Marco F ^a   Korb, Oliver ^b   Abell, Chris ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; MICRORNA; OLIGONUCLEOTIDE; PEPTIDE NUCLEIC ACID; PROTEIN INHIBITOR; ARGONAUTE PROTEIN; EIF2C2 PROTEIN, HUMAN; PROTEIN BINDING;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; GENE SILENCING; IC 50; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN RNA BINDING; RNA ANALYSIS; ANTAGONISTS AND INHIBITORS; BINDING SITE; BIOLOGICAL MODEL; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE;

HEPATITIS C VIRUS;

ARGONAUTE PROTEINS; BASE SEQUENCE; BINDING SITES; DRUG DESIGN; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; PEPTIDE NUCLEIC ACIDS; PROTEIN BINDING; RNA INTERFERENCE;

EID: 84886493031     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb400246k     Document Type: Article

References (28)

1. Dykxhoorn, D. M., Novina, C. D., and Sharp, P. A. (2003) Killing the messenger: Short RNAs that silence gene expression Nat. Rev. Mol. Cell Biol. 4, 457-467
2. Bartel, D. P. (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function Cell 116, 281-297
3. M. R. Fabian, M. R. and Sonenberg, N. (2012) The mechanics of miRNA-mediated gene silencing: A look under the hood of miRISC Nat. Struct. Mol. Biol. 19, 586-593
4. Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., and Stoffel, M. (2005) Silencing of microRNAs in vivo with antagomirs Nature 438, 685-689
5. Koshkin, A. A., Singh, S. K., Nielsen, P., Rajwanshi, V. K., Kumar, R., Meldgaard, M., Olsen, C. E., and Wengel, J. (1998) LNA (locked nucleic acid): Synthesis of the adenine, cytosine, guanine, 5-methyl cytosine, thymine, and uracil bicyclonucleoside monomers, oligomerization, and unprecedented nucleic acid recognition Tetrahedron 54, 3607-3630
6. Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., and Ørum, H. (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327, 198-201
7. Lindow, M. and Kauppinen, S. (2012) Discovering the first microRNA-targeted drug J. Cell Biol. 199, 407-412
8. Jopling, C. L, Yi, M., Lancaster, A. M., Lemon, S. M., and Sarnow, P. (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA Science 309, 1577-1581
9. Bartel, D. P. (2009) MicroRNAs: Target recognition and regulatory functions Cell 136, 215-233
10. Obad, S., dos Santos, C. O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., Fu, C., Lindow, M., Stenvang, J., Straarup, E. M., Hansen, H. F., Koch, T., Pappin, D., Hannon, G. J., and Kauppinen, S. (2011) Silencing of microRNA families by seed-targeting tiny LNAs Nat. Genet. 43, 371-378
11. Schmidt, M. F. and Rademann, J. (2009) Dynamic template-assisted strategies in fragment-based drug discovery Trends Biotechnol. 27, 512-521
12. Schmidt, M. F., Isidro-Llobet, A., Lisurek, M., El-Dahshan, A., Tan, J., Hilgenfeld, R., and Rademann, J. (2008) Sensitized detection of inhibitory fragments and iterative development of nonpeptidic protease inhibitors by dynamic ligation screening Angew. Chem., Int. Ed. 47, 3275-3278
13. Schmidt, M. F., El-Dahshan, A., Keller, S., and Rademann, J. (2009) Selective identification of cooperatively binding fragments in a high-throughput ligation assay enables development of a picomolar caspase-3 inhibitor Angew. Chem., Int. Ed. 48, 6346-6349
14. Schmidt, M. F., Grove, M., and Rademann, J. (2011) Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases ChemBioChem 12, 2640-2646
15. Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., and Coleman, R. G. (2012) ZINC: A free tool to discover chemistry for biology J. Chem. Inf. Model. 52, 1757-1768
16. Schirle, N. T. and MacRae, I. J. (2012) The crystal structure of human Argonaute 2 Science 336, 1037-1040
17. Elkayam, E., Kuhn, C.-D., Tocilj, A., Haase, A. D., Greene, E. M., Hannon, G. J., and Joshua-Tor, L. (2012) The structure of human Argonaute-2 in complex with miR-20a Cell 150, 100-110
18. Jones, G., Willett, P., and Glen, R. C. (1995) Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation J. Mol. Biol. 245, 43-53
19. GOLD, version 5.1; (2006-2009) Cambridge Crystallographic Data Center (CCDC), Cambridge, U.K.; http://www.ccdc.cam.ac.uk/products/lifesciences/gold.
20. Korb, O., Stützle, T., and Exner, T. E. (2009) Empirical scoring functions for advanced protein-ligand docking with PLANTS J. Chem. Inf. Model. 49, 84-96
21. Liebeschuetz, J. W., Cole, J. C., and Korb, O. (2012) Pose prediction and virtual screening performance of GOLD scoring functions in a standardized test J. Comput.-Aided Mol. Des. 26, 737-748
22. Schmidt, M. F., Korb, O., Howard, N. I., Dias, M. V. B., Blundell, T. L., and Abell, C. (2013) Discovery of Schaeffer̀s acid analogues as lead structures of Mycobacterium tuberculosis type II dehydroquinase using a rational drug design approach ChemMedChem 8, 54-58
23. Porcheddu, A., Giacomelli, G., Piredda, I., Carta, M., and Nieddu, G. (2008) A practical and efficient approach to PNA monomers compatible with Fmoc-mediated solid-phase synthesis protocols Eur. J. Org. Chem. 2008, 5786-5797
24. Wang, Y., Juranek, S., Li, H., Sheng, G., Wardle, G. S., Tuschl, T., and Patel, D. J. (2009) Nucleation, propagation, and cleavage of target RNAs in Ago silencing complexes Nature 461, 754-761
25. Gasteiger, J., Rudolph, C., and Sadowski, J. (1990) Automatic generation of 3D atomic coordinates for organic molecules Tetrahedron Comput. Methodol. 3, 537-547
26. Nakanishi, K., Weinberg, D. E., Bartel, D. P., and Patel, D. J. (2012) Structure of yeast Argonaute with guide RNA Nature 486, 368-374
27. Rivas, F. V., Tolia, N. H., Song, J.-J., Aragon, J. P., Liu, J., Hannon, G. J., and Joshua-Tor, L. (2005) Purified Argonaute 2 and an siRNA form recombinant human RISC Nat. Struct. Mol. Biol. 12, 340-349
28. DeLano, W. L. (2006) The PyMOL Molecular Graphics System, v.0.99rc6, DeLano Scientific LLC, San Carlos.